POINT BIOPHARMA GLOBAL INC. Capital Expenditures
POINT BIOPHARMA GLOBAL INC. reported Capital Expenditures of $17.25 million for the 9-month period ending 2023-09-30, per its 10-Q filed 2023-11-13.
Discontinued › Cash Flow › Investing Activities
us-gaap:PaymentsToAcquirePropertyPlantAndEquipment · last filed 2023-11-13
- POINT BIOPHARMA GLOBAL INC. payments to acquire property, plant, and equipment for the quarter ending 2023-09-30 was $6.39M, a 16.06% decline year-over-year.
- POINT BIOPHARMA GLOBAL INC. payments to acquire property, plant, and equipment for the quarter ending 2023-06-30 was $7.33M, a 242.73% increase year-over-year.
- POINT BIOPHARMA GLOBAL INC. payments to acquire property, plant, and equipment for the quarter ending 2023-03-31 was $3.52M, a 274.60% increase year-over-year.
- POINT BIOPHARMA GLOBAL INC. payments to acquire property, plant, and equipment for the quarter ending 2022-12-31 was $2.07M, a 16.60% decline year-over-year.
- POINT BIOPHARMA GLOBAL INC. payments to acquire property, plant, and equipment for fiscal 2022 was $12.77M, a 45.04% increase from fiscal 2021.
- POINT BIOPHARMA GLOBAL INC. payments to acquire property, plant, and equipment for fiscal 2021 was $8.80M, a 10.16% decline from fiscal 2020.
- POINT BIOPHARMA GLOBAL INC. payments to acquire property, plant, and equipment for fiscal 2020 was $9.80M.
| Period end | Payments to Acquire Property, Plant, and Equipment 3 month | Payments to Acquire Property, Plant, and Equipment 6 month | Payments to Acquire Property, Plant, and Equipment 6 month as first filed | Payments to Acquire Property, Plant, and Equipment 9 month | Payments to Acquire Property, Plant, and Equipment 9 month as first filed | Payments to Acquire Property, Plant, and Equipment 12 month |
|---|---|---|---|---|---|---|
| 2023-09-30 | $6.39M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-13 | $13.72M derived: sum of 2 quarters · filed 2023-11-13 | $17.25M 10-Q · filed 2023-11-13 | $19.32M derived: sum of 4 quarters · filed 2023-11-13 | ||
| 2023-06-30 | $7.33M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-14 | $10.86M 10-Q · filed 2023-08-14 | $12.93M derived: sum of 3 quarters · filed 2023-08-14 | $20.54M derived: sum of 4 quarters · filed 2023-11-13 | ||
| 2023-03-31 | $3.52M 10-Q · filed 2023-05-15 | $5.59M derived: sum of 2 quarters · filed 2023-05-15 | $13.21M derived: sum of 3 quarters · filed 2023-11-13 | $15.35M derived: sum of 4 quarters · filed 2023-11-13 | ||
| 2022-12-31 | $2.07M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-27 | $9.69M derived: sum of 2 quarters · filed 2023-11-13 | $11.83M derived: sum of 3 quarters · filed 2023-11-13 | $12.77M 10-K · filed 2023-03-27 | ||
| 2022-09-30 | $7.62M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-13 | $9.76M derived: sum of 2 quarters · filed 2023-11-13 | $10.70M 10-Q · filed 2023-11-13 | $13.18M derived: sum of 4 quarters · filed 2023-11-13 | ||
| 2022-06-30 | $2.14M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-14 | $3.08M 10-Q · filed 2023-08-14 | $5.56M derived: sum of 3 quarters · filed 2023-08-14 | $8.64M derived: sum of 4 quarters · filed 2023-08-14 | ||
| 2022-03-31 | $940.93K 10-Q · filed 2023-05-15 | $3.42M derived: sum of 2 quarters · filed 2023-05-15 | $6.50M derived: sum of 3 quarters · filed 2023-05-15 | $9.56M derived: sum of 4 quarters · filed 2023-05-15 | ||
| 2021-12-31 | $2.48M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-27 | $5.56M derived: sum of 2 quarters · filed 2023-03-27 | $8.62M derived: sum of 3 quarters · filed 2023-03-27 | $8.80M 10-K · filed 2023-03-27 | ||
| 2021-09-30 | $3.08M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-14 | $6.13M derived: sum of 2 quarters · filed 2022-11-14 | $6.32M 10-Q · filed 2022-11-14 | $8.10M 10-Q · filed 2021-11-12 | $10.03M derived: sum of 4 quarters · filed 2022-11-14 | |
| 2021-06-30 | $3.06M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-12 | $3.24M 10-Q · filed 2022-08-12 | $5.86M 10-Q · filed 2021-08-13 | $6.95M derived: sum of 3 quarters · filed 2022-08-12 | ||
| 2021-03-31 | $186.80K 10-Q · filed 2022-05-13 | $3.89M derived: sum of 2 quarters · filed 2022-05-13 | ||||
| 2020-12-31 | $3.71M derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-25 | $9.80M 10-K · filed 2022-03-25 | ||||
| 2020-09-30 | $6.09M 10-Q · filed 2021-11-12 |